ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,662, issued on Aug. 11, was assigned to Prilenia Neurotherapeutics Ltd. (Yakum, Israel).
"Use of pridopidine and analogs for treating Rett syndrome" was invented by Michael Hayden (Yakum, Israel) and Michal Geva (Even-Yehuda, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "The subject invention provides a method for treating a subject afflicted with Rett syndrome comprising administering to the subject a pharmaceutical composition comprising pridopidine or pharmaceutical acceptable salts and at least one of compounds 1-8 or pharmaceutical acceptable salt thereof disclosed herein, so as to thereby treat the subject."
The patent was filed on No...